Headlines

Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned

Published by Global Banking & Finance Review

Posted on February 5, 2025

1 min read

· Last updated: January 26, 2026

Add as preferred source on Google
Novo Nordisk CEO Lars Fruergaard Jorgensen discussing tariff impacts - Global Banking & Finance Review
Novo Nordisk CEO Lars Fruergaard Jorgensen addresses potential tariffs from Trump and their impact on the company, showcasing confidence in business positioning amid economic challenges.
Global Banking & Finance Awards 2026 — Call for Entries

Novo Nordisk Faces Potential Tariffs, Stays Confident

LONDON (Reuters) - Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, its chief executive said on Wednesday, but it is confident its business is well-positioned.

Novo Nordisk CEO Lars Fruergaard Jorgensen was speaking to journalists at the company's headquarters just outside Copenhagen after the company reported fourth-quarter earnings.

(Reporting by Maggie Fick; Editing by Emelia Sithole-Matarise)

Key Takeaways

  • Novo Nordisk may be affected by Trump's EU tariffs.
  • CEO Lars Fruergaard Jorgensen remains confident in business positioning.
  • The company reported its fourth-quarter earnings.
  • The announcement was made at the Copenhagen headquarters.
  • Tariffs could impact the pharmaceutical industry.

Frequently Asked Questions

What is the main topic?
The article discusses Novo Nordisk's potential exposure to tariffs imposed by the Trump administration on the EU and its business outlook.
How is Novo Nordisk responding to the tariff threat?
Novo Nordisk's CEO expressed confidence in the company's business positioning despite the potential tariffs.
Where did the CEO make the announcement?
The announcement was made at Novo Nordisk's headquarters near Copenhagen.

Related Articles

More from Headlines

Explore more articles in the Headlines category